These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2674845)

  • 21. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma].
    Werner W; Smesny S; Schubert J
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):519-27. PubMed ID: 10996943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells.
    Rebel JM; Thijssen CD; Vermey M; Delouvée A; Zwarthoff EC; Van der Kwast TH
    Cancer Res; 1994 Oct; 54(20):5488-92. PubMed ID: 7923182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders.
    Koss LG; Tiamson EM; Robbins MA
    JAMA; 1974 Jan; 227(3):281-6. PubMed ID: 4859656
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
    Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
    J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma.
    Pagano F; Garbeglio A; Milani C; Bassi P; Pegoraro V
    Eur Urol; 1987; 13(3):145-9. PubMed ID: 3609087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
    Donat SM; Bayuga S; Herr HW; Berwick M
    J Urol; 2003 Nov; 170(5):1777-80. PubMed ID: 14532774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in grading at bladder tumor recurrence].
    Uchida T; Kobayashi K; Arakawa T; Omata T; Endo T; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Dec; 30(12):1785-91. PubMed ID: 6532206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
    Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
    Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
    Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
    J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A; Buettner R; Jakse G
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
    Copp HL; Chin JL; Conaway M; Theodorescu D
    Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.
    Holmäng S; Hedelin H; Anderström C; Johansson SL
    J Urol; 1995 Jun; 153(6):1823-6; discussion 1826-7. PubMed ID: 7752327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.